Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.52245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Jiahui Mai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shenzhen Children's Hospital of China Medical University, No. 7019 Yitian Road, Futian District, Shenzhen, 518038, Guangdong…. Hauptthemen laut MEDLINE: Dystrophin, Muscular Dystrophy, Duchenne, Chromosome Mapping. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children's Hospital, Shenzhen Key Medical Discipline Construction Fund.
Abstract (Originalsprache)
Objective
Approximately 7% of individuals with dystrophinopathy remain undiagnosed at the genetic level using conventional genetic tests like multiplex ligation‐dependent probe amplification (MLPA) and next‐generation sequencing (NGS). We used the optical genome mapping (OGM) technology to detect and analyze uncommon mutations or structural variations (SVs) within the DMD gene, thus contributing to more precise clinical diagnoses.
Methods
We herein included eight patients with dystrophinopathy (six males and two females) in whom pathogenic variants of the DMD gene could not be accurately identified using MLPA and NGS. Clinical data were collected for all patients and genetic testing was performed using OGM.
Results
Conventional methods (MLPA and NGS) failed to detect pathogenic mutations in six out of eight individuals (four males and two females). OGM testing uncovered rare mutations in the DMD gene in four patients, including a pericentric inversion in chromosome X (one male), a complex rearrangement (one male), and two X–autosome translocations (two females). No mutations were detected in the remaining two male patients. OGM also accurately mapped balanced X–autosome translocations in female patients, defining chromosomal breakpoints. In the other two male patients in whom MLPA suggested non‐contiguous exon duplications or deletions in the DMD gene, OGM characterized one case as a complex rearrangement and the other as a deletion within the DMD gene.
Interpretation
OGM is a valuable diagnostic tool for dystrophinopathy patients with negative results from conventional genetic tests. It can effectively elucidate complex SVs and pinpoint breakpoints in X–autosomal translocations in female patients, facilitating prompt and appropriate interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shenzhen Children's Hospital of China Medical University, No. 7019 Yitian Road, Futian District, Shenzhen, 518038, Guangdong, PR China.
- Department of Neurology, Shenzhen Children's Hospital, No. 7019 Yitian Road, Futian District, Shenzhen, 518038, Guangdong, PR China.
- Shenzhen A-Smart Medical Research Center, Room 516, Shenzhen Research Institute of the Chinese University of Hong Kong, 10, 2nd Yuexing Road, Nanshan District, Shenzhen, 518000, Guangdong, China.
- The Chinese University of Hong Kong-Shandong University (CUHK-SDU) Joint Laboratory on Reproductive Genetics, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
ORCID-Profile: Jiahui Mai
Förderung
- Shenzhen Science and Technology Program
- Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children's Hospital
- Shenzhen Key Medical Discipline Construction Fund
- Guangdong High-Level Hospital Construction Fund
- Sanming Project of Medicine in Shenzhen
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Mai, J., Duan, J., Chen, X., Liu, L., Liang, D., Fu, T., Lu, G., Chan, W. Y., Luo, X., Wen, F., Liao, J., Li, Z., & Lu, X. (2025). Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52245
Vancouver
Mai J, Duan J, Chen X, Liu L, Liang D, Fu T, et al. Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52245
BibTeX
@article{Mai2025,
author = {Mai, Jiahui and Duan, Jing and Chen, Xiaoyu and Liu, Liqin and Liang, Dachao and Fu, Tao and Lu, Gang and Chan, Wai Yee and Luo, Xufeng and Wen, Feiqiu and Liao, Jianxiang and Li, Zhuo and Lu, Xinguo},
title = {Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.52245}
}
EUVIMED